Genomics in Cancer Care Market By Technology (Next-Generation Sequencing, Comparative Genomic Hybridization, Fluorescence In Situ Hybridization), By Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer), By Application (Diagnostic Testing, Prognostic Testing, Treatment Selection, Monitoring Response to Therapy), By Sample Type (Blood, Tissue, Urine), By Clinical Setting (Hospital-Based Laboratories, Commercial Laboratories, Research Institutions), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

Table of Contents

1. Methodology & Report Coverage

1.1. Definition & Objective

1.2. Market Evaluation & forecast parameter

1.3. Research Methodology

1.4. Data Validation Sources

1.4.1. Secondary Research

1.4.2. Primary Research

2. Market Overview

3. Genomics in Cancer Care Market: Market Dynamics

3.1. Executive Summary

3.2. Market Driving Factors

3.2.1. Advancements in next-generation sequencing enhance precision oncology and personalized cancer treatment.

3.2.2. Rising cancer prevalence increases demand for genomic diagnostics and targeted therapies.

3.2.3. Government initiatives and funding boost cancer genomics research and clinical applications.

3.3. Key industry pitfalls & challenges

3.3.1. High costs of genomic testing limit accessibility in low-income regions.

3.3.2. Data privacy concerns pose challenges in sharing and storing genomic information.

3.3.3. Regulatory complexities delay approvals for new genomic-based cancer diagnostics.

3.4. Market Opportunities

3.4.1. Growing adoption of liquid biopsies enhances non-invasive cancer detection and monitoring.

3.4.2. Integration of artificial intelligence accelerates genomic data analysis and interpretation.

3.4.3. Expanding applications of companion diagnostics support precision medicine in oncology treatments.

3.5. Porter’s Five Forces Analysis

3.6. PESTLE Analysis

3.7. Regulatory landscape

3.8. Investment Landscape

3.9. ESG Scenario

3.10. Competitive landscape

3.10.1. Company Market Share

3.10.2. Market Positioning

3.10.3. Strategy framework

3.10.4. Recent Acquisitions & Mergers

4. Genomics in Cancer Care Market, Technology Segment Analysis

4.1. Overview Dynamics

4.1.1. Market Revenue Share, By Technology, 2025 & 2035

4.1.2. Key Market Trends, Growth Factors, & Opportunities

4.2. Next-Generation Sequencing

4.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.3. Comparative Genomic Hybridization

4.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.4. Fluorescence In Situ Hybridization

4.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

5. Genomics in Cancer Care Market, Cancer Type Segment Analysis

5.1. Overview

5.1.1. Market Revenue Share, By Cancer Type, 2025 & 2035

5.1.2. Key Market Trends, Growth Factors, & Opportunities

5.2. Breast Cancer

5.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.3. Lung Cancer

5.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.4. Colorectal Cancer

5.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

6. Genomics in Cancer Care Market, Application Segment Analysis

6.1. Overview

6.1.1. Market Revenue Share, By Application, 2025 & 2035

6.1.2. Key Market Trends, Growth Factors, & Opportunities

6.2. Diagnostic Testing

6.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

6.3. Prognostic Testing

6.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

6.4. Treatment Selection

6.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

6.5. Monitoring Response to Therapy

6.5.1. Market Size and Forecast, 2025-2035 (USD Billion)

7. Genomics in Cancer Care Market, Sample Type Segment Analysis

7.1. Overview

7.1.1. Market Revenue Share, By Sample Type, 2025 & 2035

7.1.2. Key Market Trends, Growth Factors, & Opportunities

7.2. Blood

7.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

7.3. Tissue

7.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

7.4. Urine

7.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

8. Genomics in Cancer Care Market, Clinical Setting Segment Analysis

8.1. Overview

8.1.1. Market Revenue Share, By Clinical Setting, 2025 & 2035

8.1.2. Key Market Trends, Growth Factors, & Opportunities

8.2. Hospital-based laboratories

8.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

8.3. Commercial Laboratories

8.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

8.4. Research Institutions

8.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

9. Genomics in Cancer Care Market, Region Segment Analysis

9.1. Overview

9.1.1. Global Market Revenue Share, By Region, 2025 & 2035

9.1.2. Global Market Revenue, By Region, 2025-2035 (USD Billion)

9.2. North America

9.2.1. North America Market Revenue, By Country, 2025-2035 (USD Billion)

9.2.2. North America Market Revenue, By Technology, 2025-2035

9.2.3. North America Market Revenue, By Cancer Type, 2025-2035

9.2.4. North America Market Revenue, By Application, 2025-2035

9.2.5. North America Market Revenue, By Sample Type, 2025-2035

9.2.6. North America Market Revenue, By Clinical Setting, 2025-2035

9.2.7. The U.S.

9.2.7.1. U.S. Market Revenue, By Technology, 2025-2035

9.2.7.2. U.S. Market Revenue, By Cancer Type, 2025-2035

9.2.7.3. U.S. Market Revenue, By Application, 2025-2035

9.2.7.4. U.S. Market Revenue, By Sample Type, 2025-2035

9.2.7.5. U.S. Market Revenue, By Clinical Setting, 2025-2035

9.2.8. Canada

9.2.8.1. Canada Market Revenue, By Technology, 2025-2035

9.2.8.2. Canada Market Revenue, By Cancer Type, 2025-2035

9.2.8.3. Canada Market Revenue, By Application, 2025-2035

9.2.8.4. Canada Market Revenue, By Sample Type, 2025-2035

9.2.8.5. Canada Market Revenue, By Clinical Setting, 2025-2035

9.3. Europe

9.3.1. Europe Market Revenue, By Country, 2025-2035 (USD Billion)

9.3.2. Europe Market Revenue, By Technology, 2025-2035

9.3.3. Europe Market Revenue, By Cancer Type, 2025-2035

9.3.4. Europe Market Revenue, By Application, 2025-2035

9.3.5. Europe Market Revenue, By Sample Type, 2025-2035

9.3.6. Europe Market Revenue, By Clinical Setting, 2025-2035

9.3.7. Germany

9.3.7.1. Germany Market Revenue, By Technology, 2025-2035

9.3.7.2. Germany Market Revenue, By Cancer Type, 2025-2035

9.3.7.3. Germany Market Revenue, By Application, 2025-2035

9.3.7.4. Germany Market Revenue, By Sample Type, 2025-2035

9.3.7.5. Germany Market Revenue, By Clinical Setting, 2025-2035

9.3.8. France

9.3.8.1. France Market Revenue, By Technology, 2025-2035

9.3.8.2. France Market Revenue, By Cancer Type, 2025-2035

9.3.8.3. France Market Revenue, By Application, 2025-2035

9.3.8.4. France Market Revenue, By Sample Type, 2025-2035

9.3.8.5. France Market Revenue, By Clinical Setting, 2025-2035

9.3.9. U.K.

9.3.9.1. U.K. Market Revenue, By Technology, 2025-2035

9.3.9.2. U.K. Market Revenue, By Cancer Type, 2025-2035

9.3.9.3. U.K. Market Revenue, By Application, 2025-2035

9.3.9.4. U.K. Market Revenue, By Sample Type, 2025-2035

9.3.9.5. U.K. Market Revenue, By Clinical Setting, 2025-2035

9.3.10. Italy

9.3.10.1. Italy Market Revenue, By Technology, 2025-2035

9.3.10.2. Italy Market Revenue, By Cancer Type, 2025-2035

9.3.10.3. Italy Market Revenue, By Application, 2025-2035

9.3.10.4. Italy Market Revenue, By Sample Type, 2025-2035

9.3.10.5. Italy Market Revenue, By Clinical Setting, 2025-2035

9.3.11. Spain

9.3.11.1. Spain Market Revenue, By Technology, 2025-2035

9.3.11.2. Spain Market Revenue, By Cancer Type, 2025-2035

9.3.11.3. Spain Market Revenue, By Application, 2025-2035

9.3.11.4. Spain Market Revenue, By Sample Type, 2025-2035

9.3.11.5. Spain Market Revenue, By Clinical Setting, 2025-2035

9.3.12. Rest of Europe

9.3.12.1. Rest of Europe Market Revenue, By Technology, 2025-2035

9.3.12.2. Rest of Europe Market Revenue, By Cancer Type, 2025-2035

9.3.12.3. Rest of Europe Market Revenue, By Application, 2025-2035

9.3.12.4. Rest of Europe Market Revenue, By Sample Type, 2025-2035

9.3.12.5. Rest of Europe Market Revenue, By Clinical Setting, 2025-2035

9.4. Asia Pacific

9.4.1. Asia Pacific Market Revenue, By Country, 2025-2035 (USD Billion)

9.4.2. Asia Pacific Market Revenue, By Technology, 2025-2035

9.4.3. Asia Pacific Market Revenue, By Cancer Type, 2025-2035

9.4.4. Asia Pacific Market Revenue, By Application, 2025-2035

9.4.5. Asia Pacific Market Revenue, By Sample Type, 2025-2035

9.4.6. Asia Pacific Market Revenue, By Clinical Setting, 2025-2035

9.4.7. China

9.4.7.1. China Market Revenue, By Technology, 2025-2035

9.4.7.2. China Market Revenue, By Cancer Type, 2025-2035

9.4.7.3. China Market Revenue, By Application, 2025-2035

9.4.7.4. China Market Revenue, By Sample Type, 2025-2035

9.4.7.5. China Market Revenue, By Clinical Setting, 2025-2035

9.4.8. Japan

9.4.8.1. Japan Market Revenue, By Technology, 2025-2035

9.4.8.2. Japan Market Revenue, By Cancer Type, 2025-2035

9.4.8.3. Japan Market Revenue, By Application, 2025-2035

9.4.8.4. Japan Market Revenue, By Sample Type, 2025-2035

9.4.8.5. Japan Market Revenue, By Clinical Setting, 2025-2035

9.4.9. India

9.4.9.1. India Market Revenue, By Technology, 2025-2035

9.4.9.2. India Market Revenue, By Cancer Type, 2025-2035

9.4.9.3. India Market Revenue, By Application, 2025-2035

9.4.9.4. India Market Revenue, By Sample Type, 2025-2035

9.4.9.5. India Market Revenue, By Clinical Setting, 2025-2035

9.4.10. Australia

9.4.10.1. Australia Market Revenue, By Technology, 2025-2035

9.4.10.2. Australia Market Revenue, By Cancer Type, 2025-2035

9.4.10.3. Australia Market Revenue, By Application, 2025-2035

9.4.10.4. Australia Market Revenue, By Sample Type, 2025-2035

9.4.10.5. Australia Market Revenue, By Clinical Setting, 2025-2035

9.4.11. South Korea

9.4.11.1. South Korea Market Revenue, By Technology, 2025-2035

9.4.11.2. South Korea Market Revenue, By Cancer Type, 2025-2035

9.4.11.3. South Korea Market Revenue, By Application, 2025-2035

9.4.11.4. South Korea Market Revenue, By Sample Type, 2025-2035

9.4.11.5. South Korea Market Revenue, By Clinical Setting, 2025-2035

9.4.12. Singapore

9.4.12.1. Singapore Market Revenue, By Technology, 2025-2035

9.4.12.2. Singapore Market Revenue, By Cancer Type, 2025-2035

9.4.12.3. Singapore Market Revenue, By Application, 2025-2035

9.4.12.4. Singapore Market Revenue, By Sample Type, 2025-2035

9.4.12.5. Singapore Market Revenue, By Clinical Setting, 2025-2035

9.4.13. Rest of Asia Pacific

9.4.13.1. Rest of Asia Pacific Market Revenue, By Technology, 2025-2035

9.4.13.2. Rest of Asia Pacific Market Revenue, By Cancer Type, 2025-2035

9.4.13.3. Rest of Asia Pacific Market Revenue, By Application, 2025-2035

9.4.13.4. Rest of Asia Pacific Market Revenue, By Sample Type, 2025-2035

9.4.13.5. Rest of Asia Pacific Market Revenue, By Clinical Setting, 2025-2035

9.5. Latin America

9.5.1. Latin America Market Revenue, By Country, 2025-2035 (USD Billion)

9.5.2. Latin America Market Revenue, By Technology, 2025-2035

9.5.3. Latin America Market Revenue, By Cancer Type, 2025-2035

9.5.4. Latin America Market Revenue, By Application, 2025-2035

9.5.5. Latin America Market Revenue, By Sample Type, 2025-2035

9.5.6. Latin America Market Revenue, By Clinical Setting, 2025-2035

9.5.7. Brazil

9.5.7.1. Brazil Market Revenue, By Technology, 2025-2035

9.5.7.2. Brazil Market Revenue, By Cancer Type, 2025-2035

9.5.7.3. Brazil Market Revenue, By Application, 2025-2035

9.5.7.4. Brazil Market Revenue, By Sample Type, 2025-2035

9.5.7.5. Brazil Market Revenue, By Clinical Setting, 2025-2035

9.5.8. Argentina

9.5.8.1. Argentina Market Revenue, By Technology, 2025-2035

9.5.8.2. Argentina Market Revenue, By Cancer Type, 2025-2035

9.5.8.3. Argentina Market Revenue, By Application, 2025-2035

9.5.8.4. Argentina Market Revenue, By Sample Type, 2025-2035

9.5.8.5. Argentina Market Revenue, By Clinical Setting, 2025-2035

9.5.9. Mexico

9.5.9.1. Mexico Market Revenue, By Technology, 2025-2035

9.5.9.2. Mexico Market Revenue, By Cancer Type, 2025-2035

9.5.9.3. Mexico Market Revenue, By Application, 2025-2035

9.5.9.4. Mexico Market Revenue, By Sample Type, 2025-2035

9.5.9.5. Mexico Market Revenue, By Clinical Setting, 2025-2035

9.5.10. Rest of Latin America

9.5.10.1. Rest of Latin America Market Revenue, By Technology, 2025-2035

9.5.10.2. Rest of Latin America Revenue, By Cancer Type, 2025-2035

9.5.10.3. Rest of Latin America Market Revenue, By Application, 2025-2035

9.5.10.4. Rest of Latin America Market Revenue, By Sample Type, 2025-2035

9.5.10.5. Rest of Latin America Market Revenue, By Clinical Setting, 2025-2035

9.6. MEA

9.6.1. MEA Market Revenue, By Country, 2025-2035 (USD Billion)

9.6.2. MEA Market Revenue, By Technology, 2025-2035

9.6.3. MEA Market Revenue, By Cancer Type, 2025-2035

9.6.4. MEA Market Revenue, By Application, 2025-2035

9.6.5. MEA Market Revenue, By Sample Type, 2025-2035

9.6.6. MEA Market Revenue, By Clinical Setting, 2025-2035

9.6.7. GCC Countries

9.6.7.1. GCC Countries Market Revenue, By Technology, 2025-2035

9.6.7.2. GCC Countries Market Revenue, By Cancer Type, 2025-2035

9.6.7.3. GCC Countries Market Revenue, By Application, 2025-2035

9.6.7.4. GCC Countries Market Revenue, By Sample Type, 2025-2035

9.6.7.5. GCC Countries Market Revenue, By Clinical Setting, 2025-2035

9.6.8. South Africa

9.6.8.1. South Africa Market Revenue, By Technology, 2025-2035

9.6.8.2. South Africa Market Revenue, By Cancer Type, 2025-2035

9.6.8.3. South Africa Market Revenue, By Application, 2025-2035

9.6.8.4. South Africa Market Revenue, By Sample Type, 2025-2035

9.6.8.5. South Africa Market Revenue, By Clinical Setting, 2025-2035

9.6.9. Rest of Middle-East & Africa

9.6.9.1. Rest of Middle-East & Africa Market Revenue, By Technology, 2025-2035

9.6.9.2. Rest of Middle-East & Africa Market Revenue, By Cancer Type, 2025-2035

9.6.9.3. Rest of Middle-East & Africa Market Revenue, By Application, 2025-2035

9.6.9.4. Rest of Middle-East & Africa Market Revenue, By Sample Type, 2025-2035

9.6.9.5. Rest of Middle-East & Africa Market Revenue, By Clinical Setting, 2025-2035

10. Company Profile

10.1. Illumina Inc.

10.1.1. Business Overview

10.1.2. Financial Performance

10.1.3. Product/Service Offerings

10.1.4. Strategies & recent developments

10.1.5. SWOT Analysis

10.2. Thermo Fisher Scientific Inc.

10.2.1. Business Overview

10.2.2. Financial Performance

10.2.3. Product/Service Offerings

10.2.4. Strategies & recent developments

10.2.5. SWOT Analysis

10.3. BGI Genomics Co., Ltd.

10.3.1. Business Overview

10.3.2. Financial Performance

10.3.3. Product/Service Offerings

10.3.4. Strategies & recent developments

10.3.5. SWOT Analysis

10.4. Agilent Technologies, Inc.

10.4.1. Business Overview

10.4.2. Financial Performance

10.4.3. Product/Service Offerings

10.4.4. Strategies & recent developments

10.4.5. SWOT Analysis

10.5. Qiagen N.V.

10.5.1. Business Overview

10.5.2. Financial Performance

10.5.3. Product/Service Offerings

10.5.4. Strategies & recent developments

10.5.5. SWOT Analysis

10.6. Pacific Biosciences of California, Inc.

10.6.1. Business Overview

10.6.2. Financial Performance

10.6.3. Product/Service Offerings

10.6.4. Strategies & recent developments

10.6.5. SWOT Analysis

10.7. 10x Genomics, Inc.

10.7.1. Business Overview

10.7.2. Financial Performance

10.7.3. Product/Service Offerings

10.7.4. Strategies & recent developments

10.7.5. SWOT Analysis

10.8. Genewiz, Inc.

10.8.1. Business Overview

10.8.2. Financial Performance

10.8.3. Product/Service Offerings

10.8.4. Strategies & recent developments

10.8.5. SWOT Analysis

10.9. Macrogen, Inc.

10.9.1. Business Overview

10.9.2. Financial Performance

10.9.3. Product/Service Offerings

10.9.4. Strategies & recent developments

10.9.5. SWOT Analysis

10.10. Oxford Nanopore Technologies Ltd.

10.10.1. Business Overview

10.10.2. Financial Performance

10.10.3. Product/Service Offerings

10.10.4. Strategies & recent developments

10.10.5. SWOT Analysis

10.11. F. Hoffmann-La Roche Ltd.

10.11.1. Business Overview

10.11.2. Financial Performance

10.11.3. Product/Service Offerings

10.11.4. Strategies & recent developments

10.11.5. SWOT Analysis

10.12. Abbott Laboratories

10.12.1. Business Overview

10.12.2. Financial Performance

10.12.3. Product/Service Offerings

10.12.4. Strategies & recent developments

10.12.5. SWOT Analysis

10.13. Bio-Rad Laboratories, Inc.

10.13.1. Business Overview

10.13.2. Financial Performance

10.13.3. Product/Service Offerings

10.13.4. Strategies & recent developments

10.13.5. SWOT Analysis

10.14. GE Healthcare

10.14.1. Business Overview

10.14.2. Financial Performance

10.14.3. Product/Service Offerings

10.14.4. Strategies & recent developments

10.14.5. SWOT Analysis

10.15. Quest Diagnostics Incorporated

10.15.1. Business Overview

10.15.2. Financial Performance

10.15.3. Product/Service Offerings

10.15.4. Strategies & recent developments

10.15.5. SWOT Analysis